SANDOZ FARMACEUTICA, LDA secures contract for 251G001485 - Acquisition Of Ustecinumab 130 Mg Sol Inj Iv Fr 26 Ml Biosimilar (Pyzchiva)

Portugal, Oct. 22 -- Portugal based SANDOZ FARMACEUTICA, LDA has secured contract from Unidade Local De Saude De Santa Maria, E. P. E. for 251G001485 - Acquisition Of Ustecinumab 130 Mg Sol Inj Iv Fr 26 Ml Biosimilar (Pyzchiva). The value of the contract is worth 1820000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....